
( Brand: Becton Dickinson ), ( Manufacturer Part Number: 9770351 ), ( Part Type: Sensor )
The Becton Dickinson (BD) Bard Sherlock 3CG Tablet Sensor BD Rite is a revolutionary blood glucose monitoring system designed for people with diabetes. This easy-to-use system is compact, portable, and offers accurate and reliable results with every test.
The heart of this system is the 3CG Tablet Sensor, which is a small, disposable sensor that is approximately the size of a 2x2 inch adhesive bandage. It is designed to be worn on the upper arm or abdomen for up to 14 days. The tablet sensor uses BD's proprietary Glucose Trend technology, which collects and transmits glucose data to the handheld reader every minute, providing real-time glucose readings and trend information.
The BD Rite MeterPro Handheld Blood Glucose Meter is the companion device to the tablet sensor. This sleek, ergonomically designed meter is easy to use, with large backlit buttons and an easy-to-read display. It can store up to 999 data points, allowing users to track their glucose trends over time. The meter can be used with regular or alternative site testing using a discreet blood test strip, and it is compatible with various types of test strips, including the BD glucose test strips (sold separately).
The BD Bard Sherlock 3CG Tablet Sensor BD Rite system offers several features that make it an excellent choice for people with diabetes. The long wear time of the tablet sensor means fewer applications, making it more convenient for users. The real-time glucose data and trend information provide valuable insights into glucose patterns and trends, helping users make informed decisions about their diabetes management. The system also features alarms for high and low glucose levels, ensuring that users are aware of any significant changes in their glucose readings.
The BD Bard Sherlock 3CG Tablet Sensor BD Rite system is CE-marked, FDA-cleared, and is available by prescription only. It is covered by many insurance plans and requires calibration with a calibration solution provided by the manufacturer. With its advanced technology, ease of use, and accurate results, the BD Bard Sherlock 3CG Tablet Sensor BD Rite system is an excellent choice for diabetes management.
The Becton Dickinson (BD) Bard Sherlock 3CG Tablet Sensor BD Rite is a coagulation monitoring system used in healthcare settings to measure INR (International Normalized Ratio) levels in patients receiving anticoagulant therapy. This device is crucial for effective management of various conditions such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, and other similar conditions. In this analysis, we will discuss the pros and cons of using the BD Bard Sherlock 3CG Tablet Sensor BD Rite.
Pros:1. Accuracy: The primary advantage of the BD Bard Sherlock 3CG Tablet Sensor BD Rite is its high level of accuracy. The system uses proprietary optics and signal processing algorithms to provide precise INR measurements.
2. Convenience: The tablet sensor design allows for easy and convenient patient sampling. Patients can carry the small, lightweight instrument and perform the test at their preferred location, reducing the need for frequent clinic visits.
3. Fast results: The system delivers reliable and fast results within minutes, enabling healthcare professionals to make timely treatment decisions.
4. Bluetooth connectivity: The BD Bard Sherlock 3CG Tablet Sensor BD Rite comes with built-in Bluetooth technology, allowing for seamless transmission of test results to healthcare providers for easy monitoring and management of patient care.
5. User-friendly: The device has an intuitive user interface, making it easy for both users and healthcare professionals to operate and interpret test results.
Cons:1. Cost: The BD Bard Sherlock 3CG Tablet Sensor BD Rite may be more expensive compared to other coagulation monitoring systems, making it less accessible for some individuals and healthcare facilities.
2. Maintenance: The system requires regular maintenance, including sensor and calibration checks, which can be time-consuming for some users.
3. Limited compatibility: The BD Bard Sherlock 3CG Tablet Sensor BD Rite may not be compatible with certain anticoagulants or situations, which could limit its utility for some patients.
4. Potential for error: Like any medical device, the BD Bard Sherlock 3CG Tablet Sensor BD Rite has the potential for human error during usage, including incorrect sample application or misinterpretation of test results.
Conclusion:The Becton Dickinson (BD) Bard Sherlock 3CG Tablet Sensor BD Rite offers several advantages, including high accuracy, convenience, fast results, Bluetooth connectivity, and user-friendliness. However, it also comes with certain disadvantages, including cost, maintenance requirements, limited compatibility, and potential for error.
In considering whether to invest in the BD Bard Sherlock 3CG Tablet Sensor BD Rite, healthcare professionals and organizations will need to weigh the benefits against the costs and determine if the advantages outweigh the limitations for their specific situations and patient populations.
Recommendation:For healthcare professionals and organizations that value precision, convenience, and fast turnaround times in INR testing, the BD Bard Sherlock 3CG Tablet Sensor BD Rite could be a worthwhile investment. However, they should carefully consider the costs and potential limitations, including the need for regular maintenance and compatibility restrictions, before making their final decision. Alternatively, they may look for cost-effective alternatives with comparable functionality if budget constraints are a significant factor.
The Sherlock 3CG TCS is designed to aid in CVAD tip positioning of catheters at least 2 Fr size through real-time navigation and electrocardiogram ECG technology. When compared to traditional PICC placement methods of blind and CXR, it has demonstrated proven time observed cost savings, specifically reduction in release patients for IV therapy, rates chest X-rays. This is the newest version tablet available from BD with activated voice commands. Fully functional and ready to go.
Sherlock 3CG TCS is indicated to be used in adult and adolescent greater than 12 through 21 patients with Cads, such as peripherally inserted central catheters Pics, venous CVS, implantable ports, immortalises catheters; it also children, infants, neonates Pics centrally Circus. Easy to transport. Super slim design. Great piece with light usage.
The Sherlock 3CG TCS is indicated as an alternative method to chest X-ray and fluoroscope for CVAD tip placement, eliminating harmful radiation.